Background Pancreaticoduodenectomy (PD) is a complex procedure, associated with a definite risk of mortality and 30-50% risk of complications. For nonampullary duodenal lesions, PD can carry a higher morbidity as they are more commonly associated with a soft pancreas and narrow-calibre main pancreatic ducts. It is therefore paramount that the risks and benefits of surgery are considered carefully in this group of patients. A preoperative histological diagnosis for duodenal lesions is normally achieved by endoscopic biopsy. In this study, we aim to assess the outcome of PD in patients with nonampullary duodenal lesions and correlate the preoperative endoscopic histology work-up with the definitive postoperative pathology. Materials and methods We reviewed a prospectively collected PD database from January 2007 to December 2013. Demographic and clinical data were included. Preoperative endoscopic histology was compared with final specimen histology to assess concordance. Results Forty patients (55% women, mean age 69.4 years, range 45-83 years) underwent PD for duodenal lesions over a 7-year time period. The most common presenting symptom was epigastric pain (32.5%), followed by anaemia (20%). Overall, the complication rate was 55%, with the most frequent adverse event being pancreatic fistula in 13/40 (32.5%). The perioperative mortality was 2/40 (5%). Duodenal adenocarcinoma (65%) was the most common postoperative histological diagnosis. The mean tumour size was 36 mm (range 5-103 mm) and a median of 13 nodes were harvested. The median length of stay was 15 days (range 7-66 days). Overall, 12/40 patients (30%) had a preoperative diagnosis of high-grade dysplasia. The postoperative specimen in this subgroup of patients was reviewed carefully and only 3/12 (25%) patients had high-grade dysplasia in the resection specimen. In the remaining patients, 3/12 (25%) had adenocarcinoma in the resection specimen and 6/12 patients (50%) had low-grade dysplasia. Conclusion PD carries a high mortality and morbidity, especially for duodenal lesions. We recommend a careful endoscopic review after the index case with a high-definition optical evaluation of duodenal lesions. This, in addition to an experienced histological assessment of the index biopsy material, forms an essential prerequisite in aiding the multidisciplinary team in the decision-making process with respect to triage of these lesions to conservative management, surveillance, endoscopic resection or finally surgical resection. Eur
Introduction
Primary nonampullary duodenal adenocarcinomas (PDACs) are uncommon tumours characterized by nonspecific symptoms and therefore a delayed presentation at diagnosis. PDACs account for just 0.3% of all gastrointestinal malignancies, but represent 25-45% of small intestinal adenocarcinomas [1] [2] [3] [4] . Two separate carcinogenic pathways of duodenal cancer have been described: the adenoma-carcinoma sequence and the denovo cancer pathway, both of which are similar to the pathways described in colon malignancies. They may also arise as part of a genetic predisposition such as familial adenomatous polyposis or Peutz-Jeghers syndrome. Duodenal polyps are uncommon, being reported in 0.3-4.6% of patients who present for oesophagogastroduodenoscopy [5] . Management of all duodenal lesions is dependent on a full evaluation of patient's symptoms, clinical features, endoscopic findings, histology and cross-sectional imaging. The management of such lesions also depends on patients' fitness for endoscopic resection or surgery. A variety of epithelial and subepithelial duodenal lesions exist ranging from lipomas to gastrointestinal stromal tumours (GISTs), neuroendocrine tumours (NETs), duodenal adenomas and finally duodenal adenocarcinomas. Historically, duodenal adenomas were managed surgically, either by radical resection or by a conservative local excision. More recently, renewed interest in advanced endoscopic approaches is emerging [6] . However, there is no consensus as yet on which duodenal adenomas should be kept under surveillance and which lesions should be removed either by endoscopy or by surgery [6, 7] . Recent results using techniques for endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD) show promising results, raising the possibility of duodenal adenoma management through endoscopy rather than the need for radical surgery. This would be an attractive approach for lesions with a low risk of cancer, but more data are required.
The preoperative histological diagnosis of duodenal lesions is achieved routinely by endoscopic biopsy, followed by cross-sectional imaging, with surgery indicated when cancer or high-grade dysplasia (HGD) is reported. Complete resection of malignant nonampullary lesions is the only option for a cure. Hence, pancreaticoduodenectomy (PD) is considered the only appropriate procedure to achieve complete oncological resection with adequate lymphadenectomy. PD is a complex procedure, associated with a definite risk of mortality and 30-50% risk of complications. It is very important therefore that any surgical intervention is scrutinized carefully. Accurate evaluation of preoperative histology is imperative to guide clinicians in making a definitive plan for surgery, given the associated mortality and morbidity. The aim of this study is to assess the outcome of PD in patients with nonampullary lesions and correlate the preoperative endoscopic, biopsy-related histology to the final histology obtained from the resection specimen.
Materials and methods
An analysis of all PD procedures was carried out for the period of January 2007 to December 2013. Of the 404 PDs performed at Southampton General Hospital over this 7-year period, 40 patients who underwent PD for primary nonampullary duodenal lesions were included in our study. All patients underwent a gastroscopy and cross-sectional imaging with both abdominal ultrasound and computed tomographic scan of their chest, abdomen and pelvis before consideration of surgery. Endoscopic evaluation and tissue acquisition of the lesion were performed in all cases. The individual patient's management was discussed and planned at a multidisciplinary meeting (MDT) after reviewing endoscopic findings, imaging and histology results. Demographic, clinical and operative data were collected. Macroscopic and microscopic pathologic findings, including the size, location, differentiation and nodal involvement of the tumour, were analysed. Preoperative endoscopic histology was compared with the final histology to assess the concordance. The preoperative and the final histology, in the subgroup of patients with low-grade dysplasia (LGD), were reviewed by our expert pathologist to confirm the diagnosis. All patients had postoperative peripheral blood tumour markers and a further interval computed tomographic scan for surveillance. The pancreatic parenchymal consistency was graded as soft or hard on the basis of intraoperative assessment by the operating surgeon. The hospital length of stay was calculated from the date of operation to the date of discharge (with both days being inclusive). Complications were graded according to the Clavien-Dindo grading system [8] . Complications such as postoperative pancreatic leak/fistula, delayed gastric emptying and postpancreatectomy haemorrhage were defined according to the International Study Group on Pancreatic Surgery guidelines [9] [10] [11] . Major pancreatic fistula was defined as fistula grades B or C. Perioperative mortality was defined as death because of any cause during hospitalization or within 30 days of surgery. We compared the perioperative outcomes of this group of patients with group B who had a PD for distal common bile duct lesions and a third group (group C) who had a PD for pancreatic and ampullary lesions. The seventh edition of American Joint Committee on Cancer classification for malignant neoplasms was used [12] .
Statistics
Statistical analyses were carried out using SPSS, version 22.0 for Windows statistical package (SPSS Inc., Chicago, Illinois, USA). Results are reported as mean SD and range or frequencies, as appropriate. Two-tailed P-values less than 0.05 were considered to be significant.
Results
Forty patients [22 women (55%) with a mean age of 69.4 years (range 45-83 years)] underwent PD for duodenal lesions. Epigastric pain was the most common presenting symptom (32.5%), followed by anaemia (20%). The majority of these lesions (57.5%) were located in the second part of the duodenum, 32.5% were located in the third part and four cases (10%) were located on the first and fourth parts of the duodenum. In our study, the four patients who had a lesion involving the first and fourth part of the duodenum had tumours extending to the adjacent part of the duodenum (D2 or D3). In addition, all these four patients had stages IIIa and IIIb adenocarcinoma. On the basis of this, the multidisciplinary meeting decision was to perform a Whipple's resection rather than a pancreas-sparing duodenal resection.
The most common preoperative diagnosis was duodenal adenocarcinoma in 23/40 (57.5%), HGD in 12/40 (30%), NET in 2/40 (5%), GIST in 2/40 (5%) and a metastasis from a caecal cancer in one patient (Table 1) .
Postoperative histology identified duodenal adenocarcinoma in 26/40 (65%) patients, LGD in 6/40 (15%) cases, HGD in 3/40 patients (7.5%), GIST in 2/40, NET in 2/40 and metastatic caecal cancer in one patient. The average tumour (lesion) size was 36 mm (range 5-103 mm). Lymph node metastasis was present in 19/40 patients; four patients underwent R1 resection. The median length of stay was 15 days (range 7-66 days). The median survival of all PDAC patients was 26 months (Fig. 1 ).
In the adenocarcinoma group (26 patients Review of the preoperative biopsies by our expert pathologist of the patients who had LGD on the final histology, but reported as HGD on the preoperative histology, confirmed the presence of LGD in the four cases in which biopsy material was available for review. One of these biopsies had originally been reported as showing adenoma with predominantly LGD and a focus suspicious for HGD, but there was no convincing evidence of HGD on review. Review of the PD specimens confirmed the presence of LGD in all six cases.
The overall complication rate was 55%, the most common complication being pancreatic fistula in 13/40 There was no significant difference in the overall complications between the three groups, but the duodenal group included a significantly higher number of patients who had a major pancreatic fistula, reoperations and intraabdominal collections ( Table 2 ). In addition, patients with duodenal and common bile duct lesions had a significant smaller size of the pancreatic duct compared with the third group (P = 0.025). The incidence of soft pancreas was found to be significantly higher in the duodenal group: 62.5% compared with 42.9 and 34.9% in groups B and C, respectively (P = 0.0001). Table 3 shows the correlation between preoperative histology obtained from endoscopic biopsy with the final histology obtained from a postoperative resection specimen. A preoperative diagnosis of cancer, GIST or NET was confirmed on the final histology of the resected specimen. However, of the 12 patients with HGD on preoperative histology, only 3/12 had HGD confirmed after surgical resection. In the remaining nine patients, six resection specimens showed LGD and 3/12 showed adenocarcinoma.
Discussion
Duodenal adenocarcinoma is a rare malignancy that accounts for less than 0.5% of gastrointestinal malignancies and where complete resection, where possible, remains the only option for cure, PD is the optimal surgical procedure to achieve this. For tumours located in the first, third or fourth portions of the duodenum, some authors have reported excellent survival and considerably lower postoperative mortality and morbidity following a limited segmental resection [13, 14] . However, some authors have suggested that all duodenal cancers should be treated by PD, where complete regional lymphadenectomy can be achieved [15, 16] .
PD is a complex procedure, associated with a definite risk of mortality and 30-50% risk of complications. Recent series from specialized surgical centres have reported mortality rates following PD to be less than 5% [17] [18] [19] [20] . However, morbidity rates remain high (30-60%) [18, 21, 22] . Postoperative complications can lead to an increased length of hospital stay and treatment cost. Pancreatic fistula continues to be the Achilles' heel of pancreatic surgeons. Most leaks run a benign course, only requiring maintenance of intraoperatively placed drains [23] . However, a pancreatic leak can lead to retroperitoneal sepsis with abscess formation and/or destruction of the surrounding tissues and blood vessels with the potential for severe haemorrhage [24] . Particular risk factors for breakdown of the pancreatic anastomosis are a soft parenchymal texture, a small main pancreatic duct in the remnant gland, a high degree of remaining pancreatic exocrine function and an anastomotic surgical technique [24] . A soft pancreas and small calibre of the main pancreatic duct are commonly encountered in patients with duodenal lesions. In our experience, 25/40 (62.5%) were associated with a soft pancreas. Pancreatic fistula was observed in 13 patients (32.5%). Interestingly, the majority of those (77%) were serious leaks (grade B fistula 46.2% and grade C 30.8%). This is a significantly high percentage of severe leaks compared with other reports on PDs for all periampullary lesions where grade A fistula is more frequent [9] .
Similarly, we observed a relatively high rate of reoperation for bleeding and sepsis in this patient group (15%). This was also higher in comparison with our patients undergoing surgery for periampullary lesions, 4% of whom underwent reoperation, which is similar to the rates reported in the literature, where the incidence has been reported to be between 2.7 and 10.8% [25] [26] [27] [28] . The postoperative mortality was 5%; again, this is significantly higher than our mortality rate for periampullary tumours, 2%, confirming the increased risks of morbidity and mortality in this subgroup of patients.
Historically, a histological diagnosis of HGD on endoscopic biopsy was considered a risk factor for the presence of invasive cancer within the lesion. However, our data show that in patients with a preoperative pinch biopsy diagnosis of HGD, 25% have carcinoma in the surgical resection specimen, a further 25% have HGD with the remaining 50% only LGD. As a tertiary centre covering a population of 3.7 million, our patients are referred from local hospitals, therefore suggesting that the discrepancy between preoperative and postoperative histological diagnosis was not associated with an individual pathologist working in one centre. Histological evaluation of specimens from secondary care hospitals can be challenging for a number of reasons. Many would agree that factors such as the size and number of the preoperative biopsy specimens, and artefacts induced by diathermy or tissue handling can make histological assessment very difficult and lead to sampling variability. In the assessment of patients with Barrett's oesophagus, guidelines recommend that all cases of suspected dysplasia should be reviewed by a second expert gastrointestinal pathologist, with review in a cancer centre if an intervention is being considered [29] . Our findings suggest that similar guidelines should be implemented for duodenal lesions to avoid an unnecessary aggressive surgical procedure. However, recent advances in endoscopic techniques such as high-definition endoscopy, chromoendoscopy, electronic imaging, magnifying endoscopy and endoscopic ultrasound with or without fine-needle aspiration should allow us to make a more accurate preoperative histological diagnosis. In addition, the advances in endoscopic resection technique such as EMR and ESD may increasingly take on a more important role in the management of these lesions. Although a definitive role of EMR and ESD in the management of cancer is yet to be defined, one would speculate that there might be a role for these techniques to strengthen the preoperative assessment. EMR would give the pathologist a large specimen for assessment. If no cancer is found, then the patient would have had a curative resection with very low morbidity. If cancer is found, the endoscopic treatment would not preclude PD or limited duodenectomy. In addition, EMR would help in determining the depth of invasion within the wall layers and the presence or absence of lymph vascular invasion [30] [31] [32] , which are important factors to be considered when a surgical option is discussed.
Conclusion
Our study confirms that PD for nonampullary duodenal lesions is associated with high mortality and morbidity. Histological assessment of specimens obtained at the time of endoscopic assessment can be challenging to interpret and may lead to unnecessary radical surgery, with its related morbidity and mortality. Clear guidelines on histological assessment and better use of advances in endoscope resolution and function are essential in reducing this margin of error and ensuring appropriate management of patients with this challenging and rare disease. The development of novel endoscopic resection techniques may offer further therapeutic and diagnostic options, which should be considered. LGD, low-grade dysplasia; NET, neuroendocrine tumour. *Two-tailed P < 0.05 (in bold) were considered to be significant.
